Terminated PHASE3 INTERVENTIONAL 2-arm NCT04539873

Impact of Colchicine in Hospitalized Colombian Patients With COVID-19 ((COLCOVID19))

Sponsor: Fundación Universitaria de Ciencias de la Salud

Interventions CONTROL GROUP Colchicine 0.5 MG

Updated 7 times since 2020 Last updated: Feb 7, 2022 Started: Apr 30, 2021 Primary completion: Oct 30, 2021 Completion: Oct 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

non-inclusion of patients in the study effectively

Other terminated trials from Fundación Universitaria de Ciencias de la Salud

More terminations from Fundación Universitaria de Ciencias de la Salud

Other Corona Virus Infection trials with similar outcome

Browse all Corona Virus Infection trials

This PHASE3 trial investigates Corona Virus Infection and is currently terminated or withdrawn. Fundación Universitaria de Ciencias de la Salud leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Mar 2022 — Jul 2024 [monthly]

Terminated PHASE3

Status: Not Yet Recruiting → Terminated
May 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE3
Mar 2021 — May 2021 [monthly]

Not Yet Recruiting PHASE3

▶ Show 2 earlier versions

Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting PHASE3
Oct 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación Universitaria de Ciencias de la Salud
Hospital de San Jose

Data source: Fundación Universitaria de Ciencias de la Salud

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bogota, Colombia